
Dihexa
CAS No. 1401708-83-5
Dihexa( PNB-0408 | N-hexanoic-Try-Ile-(6)-amino hexanoic amide | Hexanoyl-Tyr-Ile-Ahx-NH2 )
Catalog No. M20716 CAS No. 1401708-83-5
Dihexa is an activator of the hepatocyte growth factor/c-Met (HGF/c-Met) systemit binds to HGF (Kd = 65 pM)and an analog of the peptide angiotensin IV.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 81 | In Stock |
![]() ![]() |
5MG | 122 | In Stock |
![]() ![]() |
10MG | 206 | In Stock |
![]() ![]() |
25MG | 428 | In Stock |
![]() ![]() |
50MG | 626 | In Stock |
![]() ![]() |
100MG | 889 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDihexa
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihexa is an activator of the hepatocyte growth factor/c-Met (HGF/c-Met) systemit binds to HGF (Kd = 65 pM)and an analog of the peptide angiotensin IV.
-
DescriptionDihexa is an activator of the hepatocyte growth factor/c-Met (HGF/c-Met) systemit binds to HGF (Kd = 65 pM)and an analog of the peptide angiotensin IV.
-
In Vitro——
-
In Vivo——
-
SynonymsPNB-0408 | N-hexanoic-Try-Ile-(6)-amino hexanoic amide | Hexanoyl-Tyr-Ile-Ahx-NH2
-
PathwayAngiogenesis
-
Targetc-Met/HGFR
-
RecptorHGF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1401708-83-5
-
Formula Weight504.66
-
Molecular FormulaC27H44N4O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (59.45 mM)
-
SMILESCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCCCCCC(N)=O
-
Chemical Name6-[(2S3S)-2-[(2S)-2-hexanamido-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]hexanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mccoy A T Benoist C C Wright J W et al. Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents[J]. Journal of Pharmacology and Experimental Therapeutics 2013 344(1):141-154.
molnova catalog



related products
-
Altiratinib
Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor.
-
Hepln-13
Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
-
PF-04217903 methanes...
PF-04217903 is a potent, selective, ATP-competitive c-Met kinase inhibitor with Ki of 4.8 nM.